Percutaneous left Atrial Appendage Occlusion for Stroke Prevention in Patients with Atrial Fibrillation

References

• KirchhofP, BenussiS, KotechaDet al.2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J.37(38), 2893–2962 (2016).
   PubMed Web of Science ®Google Scholar
• RuffCT, GiuglianoRP, BraunwaldEet al.Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet383(9921), 955–962 (2014).
   PubMed Web of Science ®Google Scholar
• HartR, BenaventeO, McBrideR, PearceL. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann. Intern. Med.131(7), 492–501 (1999).
   PubMed Web of Science ®Google Scholar
• LakkireddyD, WindeckerS, ThalerDet al.Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE trial). Am. Heart J.211, 45–53 (2018).
   PubMed Web of Science ®Google Scholar
• ReddyVY, SievertH, HalperinJet al.Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA312(19), 1988–1998 (2014).
   PubMed Web of Science ®Google Scholar
• HolmesDRJr, KarS, PriceMJet al.Prospective randomized evaluation of the WATCHMAN left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J. Am. Coll. Cardiol.64(1), 1–12 (2014).
   PubMed Web of Science ®Google Scholar
• OsmancikP, TousekP, HermanDet al.Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study). Am. Heart J.183, 108–114 (2017).
   PubMed Web of Science ®Google Scholar
• ReddyVY, DoshiSK, KarSet al.5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J. Am. Coll. Cardiol.70(24), 2964–2975 (2017).
   PubMed Web of Science ®Google Scholar
• BodeWD, PatelN, GehiAK. Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis. J. Interv. Card. Electrophysiol.43(1), 79–89 (2015).
   PubMed Web of Science ®Google Scholar
• LiX, WenSN, LiSNet al.Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials and observational studies. Heart Rhythm13(6), 1203–1214 (2016).
   PubMed Web of Science ®Google Scholar
• SahayS, Nombela-FrancoL, Rodes-CabauJet al.Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomized trials. Heart103(2), 139–147 (2017).
   PubMed Web of Science ®Google Scholar
• Health Quality Ontario. Left atrial appendage closure device with delivery system: a health technology assessment. Ont. Health Technol. Assess. Ser.17(9), 1–106 (2017).
   Google Scholar
• WeiZ, ZhangX, WuHet al.A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation. Medicine (Baltimore)95(31), e4382 (2016).
   PubMed Web of Science ®Google Scholar
• YerasiC, LazkaniM, KolluruPet al.An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion. J. Interv. Cardiol.31(2), 197–206 (2018).
   PubMed Web of Science ®Google Scholar
• BoersmaLV, InceH, KischeSet al.Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology. Circ. Arrhythm. Electrophysiol.12(4), e006841 (2019).
   PubMed Web of Science ®Google Scholar
• LandmesserU, TondoC, CammJet al.Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. EuroIntervention14(5), e590–e597 (2018).
   PubMed Web of Science ®Google Scholar
• LandmesserU, SchmidtB, Nielsen-KudskJEet al.Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study. EuroIntervention13(7), 867–876 (2017).
   PubMed Web of Science ®Google Scholar
• LakkireddyD, WindeckerS, ThalerDet al.Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE trial). Am. Heart J.211, 45–53 (2019).
   PubMed Web of Science ®Google Scholar
• HartRG, DienerH-C, YangSet al.Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke43(6), 1511–1517 (2012).
   PubMed Web of Science ®Google Scholar
• DienerH-C, AisenbergJ, AnsellJet al.Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with nonvalvular atrial fibrillation: part 2. Eur. Heart J.38(12), 860–868 (2017).
   PubMedGoogle Scholar
• DienerH-C, AisenbergJ, AnsellJet al.Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with nonvalvular atrial fibrillation: part 1. Eur. Heart J.38(12), 852–859 (2017).
   PubMedGoogle Scholar
• DahalK, KunwarS, RijalJ, SchulmanP, LeeJ. Stroke, major bleeding and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies. Chest149(4), 951–959 (2016).
   PubMed Web of Science ®Google Scholar
• Lopez-LopezJA, SterneJAC, ThomHHZet al.Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost–effectiveness analysis. BMJ359, j5058 (2017).
   PubMedGoogle Scholar
• StaerkL, LipGY, OlesenJBet al.Stroke and recurrent hemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ351, h5876 (2015).
   PubMed Web of Science ®Google Scholar
• KimIS, KimHJ, KimTHet al.Nonvitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: a systematic review and meta-analysis. J. Cardiol.72(2), 105–112 (2018).
   PubMed Web of Science ®Google Scholar
• GliksonM, WolffR, HindricksGet al.EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion: an update. EuroIntervention15(13), 1133–1180 (2020).
   PubMed Web of Science ®Google Scholar